Andy Parker is the founder of Step Pharma. Step Pharma has raised $146M in total funding. Latest round: Series C. Based in Paris, France.
Andy Parker is the Chief Executive Officer of Step Pharma, a French biotechnology company specializing in CTPS1 inhibition for cancer treatment. He is responsible for overseeing the company's clinical trials for relapsed/refractory lymphoma, biomarker-selected solid tumors, and essential thrombocythemia. Parker has been involved with Step Pharma since its early stages, guiding its expansion from autoimmune disorders into cancer therapies.
Full founder directory · Investor directory · Company funding database · Fundraising library